MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, they Announced the deep optimization of stacked sparse autoencoders through the DeepSeek open-source ...
Patients Achieved Remission Within 30 Days in Cohort 1 of the Mipletamig RAINIER Dose Optimization Trial for Frontline AML Patients, Trial Enrollment Continues Promising Data, including a 59% Stable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback